1. Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. Issue 4 (April 2017) Authors: Middleton, Gary; Palmer, Daniel H; Greenhalf, William; Ghaneh, Paula; Jackson, Richard; Cox, Trevor; Evans, Anthony; Shaw, Victoria E; Wadsley, Jonathan; Valle, Juan W; Propper, David; Wasan, Harpreet; Falk, Stephen; Cunningham, David; Coxon, Fareeda; Ross, Paul; Madhusudan, Srinivasan; Wadd, Nic... Journal: Lancet oncology Issue: Volume 18:Issue 4(2017:Apr.) Page Start: 486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗